S10 Ep34: Midweek Takeaway with James Short, CEO of Celadon Pharmaceuticals (AIM:CEL) #CEL
In this episode of The Midweek Takeaway, Phil Carroll and Kevin Hornsby are joined by James Short, CEO of Celadon Pharmaceuticals (AIM: CEL), to discuss the company’s major strategic update. Celadon has announced plans to delist from the AIM market and transition to a private limited company, subject to shareholder approval at the upcoming General Meeting on 28 July 2025. James explains the reasoning behind this bold move, its implications for investors and patients, and how the business will continue to evolve in the medical cannabis space as a privately held company.
Disclaimer &…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.